REDWOOD CITY, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Threshold Pharmaceuticals, Inc. , today announced that it plans to report its second quarter financial results on Wednesday, August 9, 2006 after the close of the financial markets. The announcement will be followed by a conference call and webcast with the investment community at 1:30 p.m. Pacific Daylight Time.
Participating in the call from Threshold will be Barry Selick, chief executive officer, and other members of Threshold’s senior management team.
Teleconference dial-in numbers will be available in the financial results press on August 9th.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The webcast of the conference, as with other selected presentations regarding developments in Threshold’s business given by management at certain investor conferences, can be found on Threshold’s Web site, www.thresholdpharm.com, under Investors & Media. The webcast will be archived and available for replay 2 hours after the event.
About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. By selectively targeting abnormally-proliferating tumor cells, the Company’s drug candidates are designed to be potentially more effective and less toxic to healthy tissues than conventional treatments. For additional information, please visit our website (www.thresholdpharm.com).
Contact: Denise T. Powell, Sr. Director, Corporate Communications of Threshold Pharmaceuticals, Inc., +1-650-474-8206, or dpowell@thresholdpharm.com.
Threshold Pharmaceuticals, Inc.
CONTACT: Denise T. Powell, Sr. Director, Corporate Communications ofThreshold Pharmaceuticals, Inc., +1-650-474-8206, ordpowell@thresholdpharm.com
Web site: http://www.thresholdpharm.com//
